ストックスクリーナーアプリを入手
28.01
1.30%
0.36
アフターアワーズ：
28.01
前日終値:
$27.65
開ける：
$27.55
24時間の取引高:
226.19K
Relative Volume:
0.99
時価総額：
$1.32B
収益：
-
当期純損益:
$-71.58M
株価収益率:
-22.57
EPS:
-1.2413
ネットキャッシュフロー:
$-61.42M
1週間 パフォーマンス:
-1.79%
1か月 パフォーマンス:
+1.74%
6か月 パフォーマンス:
+23.66%
1年 パフォーマンス:
+115.46%
1日の値動き範囲:
$27.02
$28.04
1週間の範囲:
$26.91
$29.09
52週間の値動き範囲:
$9.80
$30.03
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-03-29 | 開始されました | Jefferies | Buy |
Enliven Therapeutics Inc (ELVN) 最新ニュース
Jones Trading Initiates Coverage of Enliven Therapeutics (ELVN) with Buy Recommendation - MSN
Enliven Therapeutics CFO Benjamin Hohl sells shares worth $178,484 By Investing.com - Investing.com South Africa
Enliven Therapeutics CFO Benjamin Hohl sells shares worth $178,484 - Investing.com
Enliven Therapeutics (ELVN) Price Target Increased by 10.75% to 35.02 - MSN
Enliven Therapeutics CFO sells $24,422 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics CFO sells $24,422 in stock - Investing.com
Enliven Therapeutics chief medical officer sells $24,482 in stock By Investing.com - Investing.com Canada
Enliven Therapeutics chief medical officer sells $24,482 in stock - Investing.com India
Enliven Therapeutics COO Anish Patel sells $21,482 in stock - Investing.com
Enliven Therapeutics COO Anish Patel sells $21,482 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics' chief scientific officer sells $25,412 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics CEO Kintz sells $27,722 in stock - Investing.com
Enliven Therapeutics' chief scientific officer sells $25,412 in stock - Investing.com India
Enliven Therapeutics director Heyman sells $47,104 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics CEO Kintz sells $27,722 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics director Heyman sells $47,104 in stock - Investing.com India
Anish Patel Sells 716 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - MarketBeat
When (ELVN) Moves Investors should Listen - Stock Traders Daily
Enliven Therapeutics, Inc. (ELVN) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
ELVN stock soars to 52-week high, reaching $28.66 By Investing.com - Investing.com Australia
Enliven Therapeutics (NASDAQ:ELVN) Reaches New 52-Week HighHere's Why - MarketBeat
Richard A. Heyman Sells 1,270 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - MarketBeat
Enliven Therapeutics Inc [ELVN] Insider Lyssikatos Joseph P sells 37,878 Shares - Knox Daily
Enliven Therapeutics Inc (ELVN) stock analysis: A simple moving average approach - US Post News
Financial Metrics Check: Enliven Therapeutics Inc (ELVN)’s Ratios for Trailing Twelve Months - The Dwinnex
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Short Interest Update - MarketBeat
Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why - Benzinga
Insider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Sells 10,420 Shares of Stock - MarketBeat
Enliven Therapeutics executive sells over $1.4 million in company stock - Investing.com India
Enliven Therapeutics director sells over $290k in company stock - Investing.com
Enliven Therapeutics director sells over $290k in company stock By Investing.com - Investing.com UK
Enliven Therapeutics (NASDAQ:ELVN) Trading Down 5.6%What's Next? - MarketBeat
Enliven Therapeutics CFO sells over $300k in company stock By Investing.com - Investing.com South Africa
Enliven Therapeutics director sells over $77k in company stock - Investing.com India
Enliven Therapeutics director sells over $77k in company stock By Investing.com - Investing.com Canada
ELVN stock soars to 52-week high, reaching $27.87 By Investing.com - Investing.com South Africa
Richard A. Heyman Sells 2,825 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - Defense World
Enliven Therapeutics CFO sells over $300k in company stock - Investing.com
Enliven Therapeutics CEO sells over $410k in company stock By Investing.com - Investing.com South Africa
Enliven Therapeutics CEO sells over $410k in company stock - Investing.com India
Enliven Therapeutics exec sells over $280k in company stock - Investing.com India
Enliven Therapeutics exec sells over $280k in company stock By Investing.com - Investing.com Canada
Enliven Therapeutics Inc (ELVN) 財務データ
収益
当期純利益
現金流量
EPS
Enliven Therapeutics Inc (ELVN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Oct 28 '24 |
Sale |
28.56 |
6,250 |
178,485 |
0 |
| Patel Anish | CHIEF OPERATING OFFICER |
Oct 18 '24 |
Sale |
30.00 |
716 |
21,483 |
343,311 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER |
Oct 18 '24 |
Sale |
30.00 |
847 |
25,413 |
1,015,188 |
| Kintz Samuel | PRESIDENT AND CEO |
Oct 18 '24 |
Sale |
30.00 |
924 |
27,723 |
1,002,892 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Oct 18 '24 |
Option Exercise |
2.48 |
814 |
2,019 |
814 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Oct 18 '24 |
Sale |
30.00 |
814 |
24,422 |
0 |
| Heyman Richard A. | Director |
Oct 18 '24 |
Sale |
30.00 |
817 |
24,512 |
123,673 |
| Heyman Richard A. | Director |
Oct 18 '24 |
Sale |
30.00 |
753 |
22,592 |
27,165 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER |
Oct 18 '24 |
Option Exercise |
2.48 |
816 |
2,024 |
816 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER |
Oct 18 '24 |
Sale |
30.00 |
816 |
24,482 |
0 |
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):